Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$29.52 -0.32 (-1.07%)
At close: Sep 29, 2026 · 4:00 PM EDT

Lakefront Biotherapeutics (LKFT) Receivables (2013 - 2026)

Updated

Lakefront Biotherapeutics (LKFT) recorded Receivables of $25.45 million in the quarter ended Mar 31, 2026, down 52.7% from $53.8 million a year earlier but up 5.6% from the prior quarter.

Analysis

Lakefront Biotherapeutics (LKFT) Receivables (2013 - 2026) Analysis & Trends

As of Dec 31, 2025, Lakefront Biotherapeutics reported Receivables of $23.39 million, down 54.5% from the prior year.

  • Annual Receivables has a five-year compound annual growth rate of -83.1% (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Receivables came in at $51.39 million in the year ended Dec 31, 2024 (+67.9%), $30.61 million in the year ended Dec 31, 2023 (-99.9%), $42.61 billion in the year ended Dec 31, 2022 (-67.7%) and $131.76 billion in the year ended Dec 31, 2021 (-22.2%).
  • Quarterly Receivables has ranged from $24.1 million in the quarter ended Dec 31, 2025 to $127.37 billion in the quarter ended Dec 31, 2021 over the past five years.
  • On a year-over-year basis, Receivables rose in two of the last six quarters, with an average decline of 7.5%.
  • Peak year-over-year performance for Receivables in the last five years was growth of 207.4% in the quarter ended Jun 30, 2021, against a decline of 99.9% in the quarter ended Dec 31, 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $24.1 million (quarter ended Dec 31, 2025), $52.99 million (quarter ended Sep 30, 2025) and $62.82 million (quarter ended Jun 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 19.05 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 13.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 9.64 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.68 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.23 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 5.06 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 12.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.13 Bn
10 Lakefront Biotherapeutics 1.97 Bn 1.97 Bn 3.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 25.45 Mn
Dec 31, 2025 24.10 Mn
Sep 30, 2025 52.99 Mn
Jun 30, 2025 62.82 Mn
Mar 31, 2025 53.80 Mn
Dec 31, 2024 50.73 Mn
Sep 30, 2024 49.89 Mn
Mar 31, 2024 59.33 Mn
Dec 31, 2023 30.61 Mn
Sep 30, 2023 51.07 Mn
Mar 31, 2023 44.48 Mn
Dec 31, 2022 41.25 Bn
Mar 31, 2022 69.24 Mn
Dec 31, 2021 127.37 Bn
Jun 30, 2021 106.14 Mn
Dec 31, 2020 176.96 Bn
Jun 30, 2020 34.53 Mn
Mar 31, 2020 29.91 Mn
Dec 31, 2019 59.78 Mn
Sep 30, 2019 6.55 Bn
API Access

Lakefront Biotherapeutics Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=LKFT&period=max&api_key=YOUR_API_KEY